Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple system atrophy: an update.

Gregor K Wenning1, Felix Geser, Michaela Stampfer-Kountchev

  • 1Department of Neurology, University Hospital, Innsbruck, Austria. gregor.wenning@uibk.ac.at

Movement Disorders : Official Journal of the Movement Disorder Society
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setting up an autonomic unit within the neurological department: a position statement of the European Federation of Autonomic Societies.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026
Same author

Immersive virtual reality upper-limb exercises in people with Parkinson's disease: an observer-blinded randomised controlled trial.

Journal of neuroengineering and rehabilitation·2026
Same author

Postural orthostatic tachycardia syndrome is the most frequent cardiovascular autonomic disorder following COVID-19 infection or vaccination.

Journal of neurology·2025
Same author

Neuropathological Characterisation of McLeod Syndrome With a Proposed New Grading System.

Neuropathology and applied neurobiology·2025
Same author

MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSA.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Putamen Structural-Functional Decoupling as an Early-Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Multiple system atrophy (MSA) is a rare neurodegenerative disease. Early identification and treatment of autonomic dysfunction are crucial, as current motor symptom treatments offer limited relief.

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Background:

  • Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder typically emerging in the early sixth decade.
  • Clinical presentation includes autonomic/urogenital failure, often with levodopa-unresponsive parkinsonism (MSA-P) or cerebellar ataxia (MSA-C).
  • Pathologically, MSA involves neuronal degeneration and glial cytoplasmic inclusions with alpha-synuclein.

Purpose of the Study:

  • To review the clinical and pathological features of Multiple System Atrophy.
  • To discuss current treatment limitations and future therapeutic strategies.
  • To highlight the importance of early diagnosis and management of autonomic dysfunction.

Main Methods:

  • Review of clinical and pathological characteristics of MSA.

Related Experiment Videos

  • Analysis of current treatment outcomes for motor and autonomic symptoms.
  • Discussion of ongoing and proposed clinical trials for neuroprotection.

    • Main Results:

    • Motor features in MSA have disappointing treatment responses, with only transient levodopa benefit in some MSA-P patients.
    • Autonomic and urogenital dysfunction in MSA can often be effectively treated if identified early.
    • Neuroprotective strategies are currently unavailable, but clinical trials are underway.

    Conclusions:

    • Early diagnosis and management of autonomic/urogenital symptoms are critical in Multiple System Atrophy care.
    • Further randomized, controlled trials are essential to find effective symptomatic or neuroprotective treatments for MSA.
    • Established research networks facilitate coordinated clinical trial activity for MSA.